The PROX1 transcription factor is responsible for the expression of the vascular endothelial growth factor receptor 3 (VEGFR3), which is stimulated by tumour-cell-derived VEGFC; this triggers tumour lymphangiogenesis and establishes the main route of dissemination for solid tumours [14,78,79,80]. This evidence concerns the gene FLT4 and neoplasm.